I'll try to rustle up some stats myself, just hoped someone had something handy.
Anectdotally speaking, I have it on good authority from a super reliable contact at UCLA that the word on Leronlimab is "encouraging, but wait for the results" which happens to mirror the current market sentiment on CYDY.